Clinical Trial Update: Pemetrexed and Erlotinib for Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating pemetrexed and erlotinib for metastatic colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• ERLOTINIB (Erlotinib)
• Pemetrexed (pemetrexed)

Snippet

Sponsor: Yonsei University | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: COMPLETED